Dermatomyositis and polymyositis (myositis) trials in Chile

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

  Where

  Concepción, Las Condes, Osorno, Santiago

  Age

  18 years to 75 years

  People

  240 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06455449